Are the ACOSOG Z0011 Trial Findings Being Applied to Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Are the ACOSOG Z0011 Trial Findings Being Applied to Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy?

Published:2017-03-13 Issue:5 Volume:23 Page:554-562
ISSN:1075-122X
Container-title:The Breast Journal
language:en
Short-container-title:Breast J

Author:

Kantor Olga¹,Pesce Catherine²³,Liederbach Erik²,Wang Chi-Hsiung⁴,Winchester David J.²³,Yao Katharine²³

Affiliation:

1. Department of Surgery; University of Chicago Medicine; Chicago Illinois

2. Department of Surgery; NorthShore University HealthSystem; Evanston Illinois

3. Pritzker School of Medicine; University of Chicago; Chicago Illinois

4. Center for Biomedical Research Informatics; NorthShore University HealthSystem; Evanston Illinois

Publisher

Hindawi Limited

Subject

Oncology,Surgery,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/tbj.12793/fullpdf

Reference28 articles.

1. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III tiral;Krag;Lancet Oncol,2007

2. Impact of immediate versus delayed axillary node dissection on surgical outcomes in breast cancer patients with positive sentinel nodes: results from the American College of Surgeons Oncology Group Trials Z0010 and Z0011;Olson;J Clin Oncol,2008

3. Impact of the American College of Surgeons Oncology Group Z0011 randomized trial on the number of axillary nodes removed for patients with early-stage breast cancer;Yao;J Am Coll Surg,2015

4. Use of neoadjuvant chemotherapy for patients with stage I to III breast cancer in the United States;Mougalian;Cancer,2015

5. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSGO Z1071 (Alliance) clinical trial;Boughey;JAMA,2013

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The use of blue dye alone for sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with initially node-positive breast cancer;European Journal of Surgical Oncology;2024-03

2. Sentinel lymph node biopsy following neoadjuvant chemotherapy: an evidence-based review and recommendations for current practice;Chinese Clinical Oncology;2023-02

3. Multidisciplinary considerations in the management of breast cancer patients receiving neoadjuvant chemotherapy;Current Problems in Surgery;2022-09

4. Impact of COVID-19 Disease in Early Breast Cancer Management: A Summary of the Current Evidence;JCO Global Oncology;2022-05

5. Management of the positive sentinel lymph node following neoadjuvant chemotherapy: results of a survey conducted with breast surgeons;ecancermedicalscience;2022-02-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3